Whilst this some of the requested information is held by the NHSBSA, we have exempted some of the figures under section 40(2) subsections 2 and 3(a) of the FOIA because it is personal data of applicants to the VDPS. This is because it would breach the first data protection principle as: a - it is not fair to disclose individual’s personal details to the world and is likely to cause damage or distress. b - these details are not of sufficient interest to the public to warrant an intrusion into the privacy of the individual. https://www.legislation.gov.uk/ukpga/2000/36/section/40 Information Commissioner Office (ICO) Guidance is that information is personal data if it ‘relates to’ an ‘identifiable individual’ regulated by the UK General Data Protection Regulation (UK GDPR) or the Data Protection Act 2018. The information relates to personal data of the VDPS claimants and is special category data in the form of health information. As a result, the claimants could be identified, when combined with other information that may be in the public domain or reasonably available. Online communities exist for those adversely affected by vaccines they have received. This further increases the likelihood that those may be identified by disclosure of this information. Section 40(2) is an absolute, prejudice-based exemption and therefore is exempt if disclosure would contravene any of the data protection principles. To comply with the lawfulness, fairness, and transparency data protection principle, we either need the consent of the data subject(s) or there must be a legitimate interest in disclosure. In addition, the disclosure must be necessary to meet the legitimate interest and finally, the disclosure must not cause unwarranted harm. The NHSBSA has considered this and does not have the consent of the data subjects to release this information and believes that it would not be possible to obtain consent that meets the threshold in Article 7 of the UK GDPR. The NHSBSA acknowledges that you have a legitimate interest in disclosure of the information to provide the full picture of data held by the NHSBSA; however, we have concluded that disclosure of the requested information would cause unwarranted harm and therefore, section 40(2) is engaged. This is because there is a reasonable expectation that patient data processed by the NHSBSA remains confidential, especially special category data. There are no reasonable alternative measures that could meet the legitimate aim. As the information is highly confidential and sensitive, it outweighs the legitimate interest in the information. Section 41 FOIA This information is also exempt under section 41 of the FOIA (information provided in confidence). This is because the requested information was provided to the NHSBSA in confidence by a third party - another individual, company, public authority or any other type of legal entity. In this instance, details have been provided by the claimants. For Section 41 to be engaged, the following criteria must be fulfilled:
Big Data Security Market Size 2025-2029
The big data security market size is forecast to increase by USD 23.9 billion, at a CAGR of 15.7% between 2024 and 2029.
The market is driven by stringent regulations mandating data protection and an increasing focus on automation in big data security. With the growing volume and complexity of data, organizations are investing significantly in advanced security solutions to mitigate risks and ensure compliance. However, implementing these solutions comes with high financial requirements, posing a challenge for smaller businesses and budget-constrained organizations. Regulations, such as the General Data Protection Regulation (GDPR) and the Health Insurance Portability and Accountability Act (HIPAA), have intensified the need for robust data security measures. These regulations demand that organizations protect sensitive data from unauthorized access, use, or disclosure.
As a result, companies are investing in big data security solutions that offer advanced encryption, access control, and threat detection capabilities. Another trend in the market is the automation of big data security processes. With the increasing volume and velocity of data, manual security processes are no longer sufficient. Automation helps organizations to respond quickly to threats and maintain continuous security monitoring. However, the high cost of implementing and maintaining these automated solutions can be a significant challenge for many organizations. Intruders, ransomware attacks, unauthorized users, and other threats pose a constant risk to valuable information, intellectual property (IP), and transactional data.
What will be the Size of the Big Data Security Market during the forecast period?
Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample
The market continues to evolve, driven by the increasing volume and complexity of data being generated and collected across various sectors. Data governance is a critical aspect of this market, ensuring the secure handling and protection of valuable information. Blue teaming, a collaborative approach to cybersecurity, plays a crucial role in identifying and mitigating threats in real-time. Risk assessment and incident response are ongoing processes that help organizations prepare for and respond to data breaches. Security monitoring, powered by advanced technologies like AI in cybersecurity, plays a vital role in detecting and responding to threats. Data masking and anonymization are essential techniques for protecting sensitive data while maintaining its usability.
Network security, cloud security, and database security are key areas of focus, with ongoing threats requiring continuous vigilance. Threat intelligence and vulnerability management help organizations stay informed about potential risks and prioritize their response efforts. Disaster recovery and business continuity planning are also essential components of a robust security strategy. Cybersecurity insurance, security auditing, access control, penetration testing, and vulnerability scanning are additional services that help organizations fortify their defenses. Zero trust security and application security are emerging areas of focus, reflecting the evolving threat landscape. The market dynamics in this space are continuously unfolding, with new challenges and solutions emerging regularly.
How is this Big Data Security Industry segmented?
The big data security industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.
Deployment
On-premises
Cloud-based
End-user
Large enterprises
SMEs
Solution
Software
Services
Geography
North America
US
Canada
Europe
France
Germany
Italy
Spain
UK
APAC
China
India
Japan
Rest of World (ROW)
By Deployment Insights
The On-premises segment is estimated to witness significant growth during the forecast period. The market: Evolution and Trends in Enterprise Computing Big Data Security encompasses a range of technologies and practices designed to protect an organization's valuable data. Traditional on-premises servers form the backbone of many enterprise data infrastructures, with businesses owning and managing their hardware and software. These infrastructures include servers and storage units, located at secure sites, requiring specialized IT support for maintenance. Data security in this context is a top priority. Companies must establish user access policies, install firewalls and antivirus software, and apply security patches promptly. Network security is crucial, with vulnerability management and threat
Not seeing a result you expected?
Learn how you can add new datasets to our index.
Whilst this some of the requested information is held by the NHSBSA, we have exempted some of the figures under section 40(2) subsections 2 and 3(a) of the FOIA because it is personal data of applicants to the VDPS. This is because it would breach the first data protection principle as: a - it is not fair to disclose individual’s personal details to the world and is likely to cause damage or distress. b - these details are not of sufficient interest to the public to warrant an intrusion into the privacy of the individual. https://www.legislation.gov.uk/ukpga/2000/36/section/40 Information Commissioner Office (ICO) Guidance is that information is personal data if it ‘relates to’ an ‘identifiable individual’ regulated by the UK General Data Protection Regulation (UK GDPR) or the Data Protection Act 2018. The information relates to personal data of the VDPS claimants and is special category data in the form of health information. As a result, the claimants could be identified, when combined with other information that may be in the public domain or reasonably available. Online communities exist for those adversely affected by vaccines they have received. This further increases the likelihood that those may be identified by disclosure of this information. Section 40(2) is an absolute, prejudice-based exemption and therefore is exempt if disclosure would contravene any of the data protection principles. To comply with the lawfulness, fairness, and transparency data protection principle, we either need the consent of the data subject(s) or there must be a legitimate interest in disclosure. In addition, the disclosure must be necessary to meet the legitimate interest and finally, the disclosure must not cause unwarranted harm. The NHSBSA has considered this and does not have the consent of the data subjects to release this information and believes that it would not be possible to obtain consent that meets the threshold in Article 7 of the UK GDPR. The NHSBSA acknowledges that you have a legitimate interest in disclosure of the information to provide the full picture of data held by the NHSBSA; however, we have concluded that disclosure of the requested information would cause unwarranted harm and therefore, section 40(2) is engaged. This is because there is a reasonable expectation that patient data processed by the NHSBSA remains confidential, especially special category data. There are no reasonable alternative measures that could meet the legitimate aim. As the information is highly confidential and sensitive, it outweighs the legitimate interest in the information. Section 41 FOIA This information is also exempt under section 41 of the FOIA (information provided in confidence). This is because the requested information was provided to the NHSBSA in confidence by a third party - another individual, company, public authority or any other type of legal entity. In this instance, details have been provided by the claimants. For Section 41 to be engaged, the following criteria must be fulfilled: